Summary
The majority of all acute upper respiratory tract infections (URTIs) are viral in aetiology. Bacterial infection, either as a prime cause or secondary to the initial viral infection, can be effectively eradicated with appropriate drug therapy. A course of penicillin is usually effective in cases of acute tonsillitis, pharyngitis, otitis media and sinusitis. Macrolide antibiotics may be prescribed as an alternative, especially if β-lactamase-producing strains are present. Roxithromycin achieves high tissue concentrations, and cure rates between 85 and 100% have been reported in various URTIs.
Keywords: Otitis Medium, Sinusitis, Pharyngitis, Roxithromycin, Respiratory Syncytial Viral Infection
References
- Bluestone C.D. Otitis media and sinusitus in children. Role of Branhamella catarrhalis. Drugs. 1986;31(Suppl. 3):132–141. doi: 10.2165/00003495-198600313-00029. [DOI] [PubMed] [Google Scholar]
- Brook I., Yocum P., Friedman E.M. Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Annals of Otology, Rhinology and Laryngology. 1981;90:261. doi: 10.1177/000348948109000313. [DOI] [PubMed] [Google Scholar]
- D’Enfert J., Fiessinger S. Rulid: un nouveau macrolide efficace en pathologie O.R.L. Les Cahiers d’O.R.L. 1988;23:141–143. [Google Scholar]
- Grassi C., Bartucci F., Sassella D. Efficacy and safety of rox-ithromycin in respiratory tract infections. British Journal of Clinical Practice. 1988;42(Suppl. 55):104–105. [Google Scholar]
- Hall C.B., McBride J.T., Walsh E.E., Bell D.M., Gala C.L., et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. New England Journal of Medicine. 1983;308:1443. doi: 10.1056/NEJM198306163082403. [DOI] [PubMed] [Google Scholar]
- Herron J.M. Roxithromycin in the therapy of Streptoccocus pyogenes throat infection. Journal of Antimicrobial Chemotherapy. 1987;20(Suppl. B):139–144. doi: 10.1093/jac/20.suppl_b.139. [DOI] [PubMed] [Google Scholar]
- Jackson R.T., Todd W.W., Turner J.S., Jr . Ear, nose and throat diseases. In: Speight T.M., editor. Avery’s drug treatment. Principles and practice of clinical pharmacology and therapeutics. 3rd. Auckland: Adis Press Ltd; 1987. pp. 360–386. [Google Scholar]
- Krober M.S., Bass J.W., Michels G.N. Streptococcal pharyngitis: placebo-controlled double-blind evaluation of clinical response to penicillin therapy. Journal of the American Medical Association. 1985;253:1271. doi: 10.1001/jama.1985.03350330069024. [DOI] [PubMed] [Google Scholar]
- Matsumoto F., Hara K. Multicentre clinical studies of roxithromycin in respiratory, otorhinolaryngological, skin and dental infections, and chlamydial sexually transmitted diseases; 1987. [Google Scholar]
- Melcher G.P. Comparative efficacy and toxicity of roxithromycin and erythromycin ethylsuccinate in the treatment of Streptococcal pharyngitis in adults. Journal of Antimicrobial Chemotherapy. 1988;22:549–556. doi: 10.1093/jac/22.4.549. [DOI] [PubMed] [Google Scholar]
- Soyka L.F., Robinson D.S., Lachant N., Monaco J. The misuse of antibiotics for treatment of upper respiratory tract infections in children. Pediatrics. 1975;55:552. [PubMed] [Google Scholar]
- Taylor B., Abbott G.D., Kerr M., Fergusson D.M. Amoxycillin and co-trimoxazole in presumed viral respiratory infections of childhood: placebo-controlled trial. British Medical Journal. 1977;2:552. doi: 10.1136/bmj.2.6086.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Young R.A., Gonzalez J.P., Sorkin E.M. Roxithromycin: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs. 1989;37:8–41. doi: 10.2165/00003495-198937010-00002. [DOI] [PubMed] [Google Scholar]